Apimeds Pharmaceuticals US Inc (APUS)

$4.55 -0.15 (-3.19%)
Market Cap 6.87M
Revenue (ttm) 0.00
Net Income (ttm) -6.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.06
Volume 21,200
Avg Vol 31,604
Day's Range N/A - N/A
Shares Out 1.51M
Stochastic %K 27%
Beta 0.15
Analysts Strong Buy
Price Target N/A

Company Profile

Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 848 201 5010
Address:
100 Matawan Rd, Suite 325, Matawan, United States
ohyesarooni
ohyesarooni Aug. 15 at 7:17 PM
$GDC 10Q Friday night 7500 bitcoin plus cash, 4 mil OS, $2 SP $120 BV ? what? NFA $KUST $APUS $YYGH
1 · Reply
Alex0989
Alex0989 Aug. 15 at 5:14 PM
$APUS $APUS is quietly becoming a powerhouse.
0 · Reply
michal360
michal360 Aug. 15 at 5:10 PM
$APUS The momentum behind $APUS is undeniable right now. If you aren't paying attention, you're missing out!
0 · Reply
forexupdates
forexupdates Aug. 15 at 5:08 PM
What stands out about $APUS is the focus on scalable execution over pure hype. Real AI integration requires high performance, and $APUS delivers.
0 · Reply
kleanthsi
kleanthsi Aug. 15 at 5:06 PM
$APUS $APUS holding strong while the rest of the market bounces around. True conviction play right here!
0 · Reply
jacobs49
jacobs49 Aug. 15 at 5:05 PM
$APUS Decentralized AI done right. $APUS to the moon!
0 · Reply
robertphiliprdx
robertphiliprdx Aug. 15 at 5:03 PM
$APUS The $APUS community is unmatched! Calm, focused and building through every market cycle.
0 · Reply
Alex0989
Alex0989 Aug. 15 at 4:52 PM
$APUS Strong tech, active developers, and a real use case. $APUS is definitely one of the most underrated projects in the AI narrative.
0 · Reply
wellhellrex
wellhellrex Aug. 14 at 5:12 PM
$APUS Our balance sheet strategy is designed to align with our DAT offering. Mindwave's wholly owned subsidiary, TechyTrade (Dubai), owns or controls 1,000 Bitcoin free of encumbrances, identifiable and segregated within a sub-wallet architecture created and administered by MindWave Ltd. https://www.sec.gov/Archives/edgar/data/1894525/000121390026051139/ea0288344-10k_apimeds.htm $RIOT $MARA
0 · Reply
mikethemage
mikethemage Aug. 13 at 2:50 AM
$APUS still holding the bag?
0 · Reply
Latest News on APUS
NILA Token Now Available to Eligible U.S. Users on Webot, a Licensed U.S. Cryptocurrency Exchange

Aug 3, 2026, 9:00 AM EDT - 13 days ago

NILA Token Now Available to Eligible U.S. Users on Webot, a Licensed U.S. Cryptocurrency Exchange

Apimeds Pharmaceuticals US Inc trading resumes

2026-07-30T13:55:40.000Z - 17 days ago

Apimeds Pharmaceuticals US Inc trading resumes

Apimeds Pharmaceuticals US Inc trading halted, volatility trading pause

2026-07-30T13:50:28.000Z - 17 days ago

Apimeds Pharmaceuticals US Inc trading halted, volatility trading pause

MindWave Innovations Inc., a Wholly Owned Subsidiary of Apimeds Pharmaceuticals US, Inc., Announces MindChain: World's First Fully Insured Blockchain, Launching in October

Jul 28, 2026, 8:30 AM EDT - 19 days ago

MindWave Innovations Inc., a Wholly Owned Subsidiary of Apimeds Pharmaceuticals US, Inc., Announces MindChain: World's First Fully Insured Blockchain, Launching in October

For Second Straight Year, American Public University System (APUS) Earns Great Place to Work® Certification

Jun 8, 2026, 9:00 AM EDT - 2 months ago

For Second Straight Year, American Public University System (APUS) Earns Great Place to Work® Certification

APEI

Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program

May 5, 2026, 2:07 PM EDT - 3 months ago

Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program

Apimeds Pharmaceuticals US Annual report: Q4 2025

May 4, 2026, 7:00 AM EDT - 3 months ago

Apimeds Pharmaceuticals US Annual report: Q4 2025

Inscobee, Apimeds Korea deliver action by written consent to remove directors

2026-03-25T11:21:47.000Z - 5 months ago

Inscobee, Apimeds Korea deliver action by written consent to remove directors

Apimeds Pharma US reports material breach of merger agreement by Inscobee

2026-03-24T12:35:14.000Z - 5 months ago

Apimeds Pharma US reports material breach of merger agreement by Inscobee

Apimeds Pharmaceuticals US Inc. Announces Material Breach of Merger Agreement by Inscobee Inc. (KS:006490) and Apimeds Inc.; Prepares Filing Emergency Action in Delaware Court of Chancery

Mar 24, 2026, 8:30 AM EDT - 5 months ago

Apimeds Pharmaceuticals US Inc. Announces Material Breach of Merger Agreement by Inscobee Inc. (KS:006490) and Apimeds Inc.; Prepares Filing Emergency Action in Delaware Court of Chancery

Apimeds Pharmaceuticals confirms FDA Type C meeting for osteoarthritis candidate

2026-02-11T21:55:14.000Z - 6 months ago

Apimeds Pharmaceuticals confirms FDA Type C meeting for osteoarthritis candidate

Apimeds Pharmaceuticals and Lōkahi Therapeutics Announce FDA Type C Meeting Scheduled for LT‑100 (Apitox)

Feb 11, 2026, 4:51 PM EST - 6 months ago

Apimeds Pharmaceuticals and Lōkahi Therapeutics Announce FDA Type C Meeting Scheduled for LT‑100 (Apitox)

Apimeds Pharmaceuticals and MindWave Innovations Announce Closing of $100MM PIPE Financing and Activation of 1,000 Bitcoin to Power AI-Driven Yield Generation Strategy

Dec 10, 2025, 9:58 AM EST - 8 months ago

Apimeds Pharmaceuticals and MindWave Innovations Announce Closing of $100MM PIPE Financing and Activation of 1,000 Bitcoin to Power AI-Driven Yield Generation Strategy

Apimeds Pharmaceuticals US Inc trading resumes

2025-12-01T14:50:10.000Z - 9 months ago

Apimeds Pharmaceuticals US Inc trading resumes

Apimeds Pharmaceuticals, MindWave Innovations announce merger

2025-12-01T14:35:27.000Z - 9 months ago

Apimeds Pharmaceuticals, MindWave Innovations announce merger

Apimeds and MindWave Announce Merger, Integrating Biotech Growth with AI-Driven Digital Treasury Yield Generation Backed by $100M PIPE

Dec 1, 2025, 9:25 AM EST - 9 months ago

Apimeds and MindWave Announce Merger, Integrating Biotech Growth with AI-Driven Digital Treasury Yield Generation Backed by $100M PIPE

Apimeds Pharmaceuticals US Inc trading halted, news pending

2025-12-01T14:05:31.000Z - 9 months ago

Apimeds Pharmaceuticals US Inc trading halted, news pending

Apimeds Pharmaceuticals US Quarterly report: Q3 2025

Nov 12, 2025, 7:00 AM EST - 9 months ago

Apimeds Pharmaceuticals US Quarterly report: Q3 2025

Apimeds Brings ai² Futures Lab™ to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation

Nov 10, 2025, 10:00 AM EST - 9 months ago

Apimeds Brings ai² Futures Lab™ to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation

Apimeds Pharmaceuticals expands AI Futures Lab program

2025-10-14T09:30:18.000Z - 10 months ago

Apimeds Pharmaceuticals expands AI Futures Lab program

Apimeds Pharmaceuticals says “I love my Ducks” with new ai² Futures Lab™ Program collaboration with the University of Oregon's Lundquist College of Business

Oct 14, 2025, 3:02 AM EDT - 10 months ago

Apimeds Pharmaceuticals says “I love my Ducks” with new ai² Futures Lab™ Program collaboration with the University of Oregon's Lundquist College of Business

Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development

Sep 15, 2025, 6:24 PM EDT - 11 months ago

Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development

Apimeds Pharmaceuticals issues statement on FDA draft guidance for pain program

2025-09-12T09:20:11.000Z - 1 year ago

Apimeds Pharmaceuticals issues statement on FDA draft guidance for pain program

Apimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program

Sep 11, 2025, 9:54 PM EDT - 1 year ago

Apimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program

Apimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai² Future Labs

Aug 25, 2025, 2:11 PM EDT - 1 year ago

Apimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai² Future Labs

Apimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters to Lead its ai² Division

Jul 15, 2025, 5:34 PM EDT - 1 year ago

Apimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters to Lead its ai² Division

Apimeds Pharmaceuticals US Slides: Corporate Presentation

Jul 15, 2025, 7:00 AM EDT - 1 year ago

Apimeds Pharmaceuticals US Slides: Corporate Presentation

Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering

May 12, 2025, 5:14 PM EDT - 1 year ago

Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering

Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering

May 8, 2025, 5:00 PM EDT - 1 year ago

Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering

ohyesarooni
ohyesarooni Aug. 15 at 7:17 PM
$GDC 10Q Friday night 7500 bitcoin plus cash, 4 mil OS, $2 SP $120 BV ? what? NFA $KUST $APUS $YYGH
1 · Reply
Alex0989
Alex0989 Aug. 15 at 5:14 PM
$APUS $APUS is quietly becoming a powerhouse.
0 · Reply
michal360
michal360 Aug. 15 at 5:10 PM
$APUS The momentum behind $APUS is undeniable right now. If you aren't paying attention, you're missing out!
0 · Reply
forexupdates
forexupdates Aug. 15 at 5:08 PM
What stands out about $APUS is the focus on scalable execution over pure hype. Real AI integration requires high performance, and $APUS delivers.
0 · Reply
kleanthsi
kleanthsi Aug. 15 at 5:06 PM
$APUS $APUS holding strong while the rest of the market bounces around. True conviction play right here!
0 · Reply
jacobs49
jacobs49 Aug. 15 at 5:05 PM
$APUS Decentralized AI done right. $APUS to the moon!
0 · Reply
robertphiliprdx
robertphiliprdx Aug. 15 at 5:03 PM
$APUS The $APUS community is unmatched! Calm, focused and building through every market cycle.
0 · Reply
Alex0989
Alex0989 Aug. 15 at 4:52 PM
$APUS Strong tech, active developers, and a real use case. $APUS is definitely one of the most underrated projects in the AI narrative.
0 · Reply
wellhellrex
wellhellrex Aug. 14 at 5:12 PM
$APUS Our balance sheet strategy is designed to align with our DAT offering. Mindwave's wholly owned subsidiary, TechyTrade (Dubai), owns or controls 1,000 Bitcoin free of encumbrances, identifiable and segregated within a sub-wallet architecture created and administered by MindWave Ltd. https://www.sec.gov/Archives/edgar/data/1894525/000121390026051139/ea0288344-10k_apimeds.htm $RIOT $MARA
0 · Reply
mikethemage
mikethemage Aug. 13 at 2:50 AM
$APUS still holding the bag?
0 · Reply
CoffeeRocks
CoffeeRocks Aug. 12 at 9:17 PM
$APUS $GLND $INHD $VEEE Don’t hold back Going back to 2$
0 · Reply
CoffeeRocks
CoffeeRocks Aug. 12 at 8:08 PM
$GLND $VEEE $INHD $APUS Meme 💦
0 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 12 at 7:23 PM
From Tokenization to Production: $APUS Positions MindChain for the Next Phase of Real-World Assets https://ibn.fm/lxKpZ
0 · Reply
wellhellrex
wellhellrex Aug. 10 at 6:11 PM
$APUS Dr. Vin Menon, CEO of MindWave Innovations, goes Inside the ICE House to discuss the growing adoption of digital asset treasury strategies by public companies. He explains how MindWave helps institutions establish Bitcoin-focused treasuries, generate yield, and navigate security and governance requirements. Menon also highlights the company’s merger with Apimeds Pharmaceuticals as a model for integrating digital assets into corporate balance sheets. He outlines how blockchain infrastructure and AI may converge to improve security, privacy, and operational efficiency across industries. https://www.youtube.com/watch?v=7IPbooIZcZs $RIOT $MARA
1 · Reply
ClassifiedTrades
ClassifiedTrades Aug. 10 at 12:55 AM
$CCHH CGTL CHSN LBGJ AEMD $APUS INLF $NEXR
0 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 7 at 7:47 PM
MindChain: Why Owning the Network Could Become the Next Phase of Enterprise Blockchain $APUS https://ibn.fm/I0kWM
0 · Reply
CoffeeRocks
CoffeeRocks Aug. 7 at 3:13 AM
$IXHL $INHD $APUS $VRAX Bull trap 🪤 or NEWS 📰????
0 · Reply
AboveNBeyond
AboveNBeyond Aug. 6 at 11:21 PM
$APUS Keep milking it guys until it will not give anymore. Catch it low sell it high. It all adds up in the long run.
0 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 6 at 7:42 PM
$APUS Positions MindChain as Institutional Blockchain Infrastructure for the Next Era of Digital Asset Adoption https://ibn.fm/qfeH2
0 · Reply
wellhellrex
wellhellrex Aug. 6 at 1:14 AM
$APUS Launching in October, MindChain is an independent Layer 2 blockchain built on a Nitro-compatible execution stack and fully compatible with the Ethereum Virtual Machine (EVM). By using Ethereum as its settlement and data availability layer, MindChain combines fast transaction execution with Ethereum-backed security. The network introduces several capabilities that support long-term ecosystem development. Near-instant transaction sequencing improves the user experience. Full EVM compatibility allows developers to build using familiar wallets and tools. Application-specific subnets provide projects with dedicated environments while benefiting from the security of the wider network. Interoperability through trusted cross-chain protocols enables assets and applications to move efficiently across blockchain ecosystems. Together, these capabilities create infrastructure designed for growth rather than simply supporting current demand. $SKYQ $BATL
0 · Reply
wellhellrex
wellhellrex Aug. 6 at 1:09 AM
$APUS The availability of $NILA.X to U.S. users through Webot since August 3 reflects this evolution. Expanding into one of the world's largest digital asset markets through a regulated platform demonstrates how responsible capital management can support broader participation while maintaining a strong commitment to governance, transparency and sustainable growth. This journey continues with the launch of MindChain, the world's first fully insured Blockchain in October 2026. Together, these milestones demonstrate how disciplined financial strategy enables ecosystems to move from ambition to execution, creating the foundation for long-term development. https://mindwavedao.net/p/mindwave-ecosystem-journal-august-2026 $SKYQ $BATL
0 · Reply
AboveNBeyond
AboveNBeyond Aug. 5 at 11:38 AM
$APUS Lets see can I pick this baby up low this morning for a swing. Guys I won't sit in this unless is shows a reversal then take the money and run unless it keeps moving up. I am sitting in things like $PATH, which has had a steady increase.
0 · Reply